NICE has recommended delgocitinib cream for adults with moderate to severe chronic hand eczema unresponsive to ...

Topicals are often the first-line treatment for psoriasis, but as the condition progresses, you may need to consider systemic treatments to manage your symptoms. Here’s what to know about your options ...

The recent FDA approval of topical JAK inhibitors for children 2 years or older marks a significant advancement in pediatric ...

United States: Projected CAGR of 5.1%, with market value rising from USD 127.3 billion in 2025 to USD 209.4 billion by 2035, ...

Meditation, biofeedback, aromatherapy, and other such therapies can relieve stress caused by psoriasis and fend off stress-triggered flares.

“The excimer laser is one of our most effective treatments for localized eczema,” said Dr. Mark G. Lebwohl, M.D., Dean for Clinical Therapeutics, Professor and Chairman Emeritus, Department of ...

The U.S. Food and Drug Administration has approved Johnson & Johnson's Tremfya (guselkumab) for the treatment of plaque ...

TREMFYA® is now approved for pediatric patients living with moderate to severe plaque psoriasis, who are candidates for systemic therapy or phototherapy, and active psoriatic arthritis in children six ...

Icotrokinra demonstrated superior skin clearance at Weeks 16 and 24 compared to deucravacitinib and similar adverse event rates to placebo in Phase 3 ICONIC-ADVANCE studies Icotrokinra also showed ...

PITTSBURGH, Sept. 16, 2025 /PRNewswire/ -- "As a registered nurse, I wanted to create an improved way to provide phototherapy treatments to newborns," said an inventor, from Ruidoso, N.M., "so I ...